Coronary Artery Disease Risk Down in Survivors of Childhood Cancer
Risk for coronary artery disease significantly decreased for survivors with diagnosis in 80s, 90s versus 70s.
Pediatric Cancer
Next-Gen Sequencing Found to Predict Bloodstream Infections in Children
At 3 days before a bloodstream infection, mcfDNA sequencing correctly predicted 12 of the 16 observed episodes.
Fertility Treatment and Childhood Cancer Risk: What’s the Link?
Of all types of fertility treatment examined, the only one that significantly increased the risk of cancer in children was frozen embryo transfer.
Survivors of Childhood Cancers at Risk for Shortened Life Span
Greatest gaps in life expectancy seen for those receiving radiotherapy, alone or combined with chemo.
Pediatric Thyroid Cancer Rates Are Rising, but Some Experts Doubt the Significance
The increased prevalence may be real, or it could be the result of the detection of more harmless tumors through increased screening efforts.
Everyone’s Conflicted: How Open Payments Did Little to Discourage Conflicts of Interest in Oncology
Since its inception, the Open Payments act does not appear to have prompted physicians to accept fewer payments from industry overall.
Differences in Postrelapse Mortality May be Driving Racial/Ethnic Disparities Observed in Children With Hodgkin Lymphoma
Study sought to determine if response to upfront treatment in children and adolescents with Hodgkin lymphoma is influenced by race/ethnicity.
Addition of Bevacizumab to Temozolomide-Based Chemotherapy Increased OR in Children With R/R Neuroblastoma
The addition of bevacizumab to temozolomide-based chemotherapy was also associated with higher rates of grade 3 or higher thrombocytopenia and anemia.
Cognitive Impairment Following Immunotherapy Treatment May Be Underestimated
As more and more patients undergo immunotherapy treatments, understanding possible side effects on cognitive function is an important research gap.
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure.
Next post in General Oncology
